| A Comparison of Attitudes Toward Opioid Agonist Treatment among Short-Term Buprenorphine Patients. | |
| | |
MedLine Citation:
|
PMID: 22242643 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Background: Obtaining data on attitudes toward buprenorphine and methadone of opioid-dependent individuals in the United States may help fashion approaches to increase treatment entry and improve patient outcomes. Objectives: This secondary analysis study compared attitudes toward methadone and buprenorphine of opioid-dependent adults entering short-term buprenorphine treatment (BT) with opioid-dependent adults who are either entering methadone maintenance treatment or not entering treatment. Methods: The 417 participants included 132 individuals entering short-term BT, 191 individuals entering methadone maintenance, and 94 individuals not seeking treatment. Participants were administered an Attitudes toward Methadone scale and its companion Attitudes toward Buprenorphine scale. Demographic characteristics for the three groups were compared using χ(2) tests of independence and one-way analysis of variance. A repeated-measures multivariate analysis of variance with planned contrasts was used to compare mean attitude scores among the groups. Results: Participants entering BT had significantly more positive attitudes toward buprenorphine than toward methadone (p < .001) and more positive attitudes toward BT than methadone-treatment (MT) participants and out-of-treatment (OT) participants (p < .001). In addition, BT participants had less positive attitudes toward methadone than participants entering MT (p < .001). Conclusions: Participants had a clear preference for a particular medication. Offering a choice of medications to OT individuals might enhance their likelihood of entering treatment. Treatment programs should offer a choice of medications when possible to new patients, and future comparative effectiveness research should incorporate patient preferences into clinical trials. Scientific Significance: These data contribute to our understanding of why people seek or do not seek effective pharmacotherapy for opioid addiction. |
| | |
Authors:
|
Sharon M Kelly; Barry S Brown; Elizabeth C Katz; Kevin E O'Grady; Shannon Gwin Mitchell; Stuart King; Robert P Schwartz |
Related Documents
:
|
1809443 - The role of litigation in predicting disability outcomes in chronic pain patients. 11056593 - Efficacy and safety of recombinant human nerve growth factor in patients with diabetic ... 21199963 - Problem-solving therapy and supportive therapy in older adults with major depression an... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-1-13 |
Journal Detail:
|
Title: The American journal of drug and alcohol abuse Volume: - ISSN: 1097-9891 ISO Abbreviation: - Publication Date: 2012 Jan |
Date Detail:
|
Created Date: 2012-1-16 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 7502510 Medline TA: Am J Drug Alcohol Abuse Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Affiliation:
|
Friends Research Institute , Baltimore, MD , USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Development of the microbial electrolysis desalination and chemical-production cell for desalination...
Next Document: Bioequivalence of two omega-3 fatty acid ethyl ester formulations: a case of clinical pharmacology o...